Bioproducts From Euglena gracilis: Synthesis and Applications.

Gissibl, A; Sun, A; Care, A; Nevalainen, H; Sunna, A

Bioproducts From Euglena gracilis: Synthesis and Applications.

Gissibl, A Sun, A Care, A

Nevalainen, H Sunna, A

Permalink

Publisher:: FRONTIERS MEDIA SA
Publication Type:: Journal Article
Citation:: Front Bioeng Biotechnol, 2019, 7, (MAY), pp. 108
Issue Date:: 2019

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (3.92 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Gissibl, A
dc.contributor.author	Sun, A
dc.contributor.author	Care, A https://orcid.org/0000-0002-0035-7961
dc.contributor.author	Nevalainen, H
dc.contributor.author	Sunna, A
dc.date.accessioned	2022-03-25T04:30:13Z
dc.date.available	2019-04-29
dc.date.available	2022-03-25T04:30:13Z
dc.date.issued	2019
dc.identifier.citation	Front Bioeng Biotechnol, 2019, 7, (MAY), pp. 108
dc.identifier.issn	2296-4185
dc.identifier.issn	2296-4185
dc.identifier.uri	http://hdl.handle.net/10453/155559
dc.description.abstract	In recent years, the versatile phototrophic protist Euglena gracilis has emerged as an interesting candidate for application-driven research and commercialisation, as it is an excellent source of dietary protein, pro(vitamins), lipids, and the β-1,3-glucan paramylon only found in euglenoids. From these, paramylon is already marketed as an immunostimulatory agent in nutraceuticals. Bioproducts from E. gracilis can be produced under various cultivation conditions discussed in this review, and their yields are relatively high when compared with those achieved in microalgal systems. Future challenges include achieving the economy of large-scale cultivation. Recent insights into the complex metabolism of E. gracilis have highlighted unique metabolic pathways, which could provide new leads for product enhancement by genetic modification of the organism. Also, development of molecular tools for strain improvement are emerging rapidly, making E. gracilis a noteworthy challenger for microalgae such as Chlorella spp. and their products currently on the market.
dc.format	Electronic-eCollection
dc.language	eng
dc.publisher	FRONTIERS MEDIA SA
dc.relation.ispartof	Front Bioeng Biotechnol
dc.relation.isbasedon	10.3389/fbioe.2019.00108
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	0699 Other Biological Sciences, 0903 Biomedical Engineering, 1004 Medical Biotechnology
dc.title	Bioproducts From Euglena gracilis: Synthesis and Applications.
dc.type	Journal Article
utslib.citation.volume	7
utslib.location.activity	Switzerland
utslib.for	0699 Other Biological Sciences
utslib.for	0903 Biomedical Engineering
utslib.for	1004 Medical Biotechnology
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
utslib.copyright.status	open_access	*
dc.date.updated	2022-03-25T04:30:08Z
pubs.issue	MAY
pubs.publication-status	Published online
pubs.volume	7
utslib.citation.issue	MAY

Abstract:

In recent years, the versatile phototrophic protist Euglena gracilis has emerged as an interesting candidate for application-driven research and commercialisation, as it is an excellent source of dietary protein, pro(vitamins), lipids, and the β-1,3-glucan paramylon only found in euglenoids. From these, paramylon is already marketed as an immunostimulatory agent in nutraceuticals. Bioproducts from E. gracilis can be produced under various cultivation conditions discussed in this review, and their yields are relatively high when compared with those achieved in microalgal systems. Future challenges include achieving the economy of large-scale cultivation. Recent insights into the complex metabolism of E. gracilis have highlighted unique metabolic pathways, which could provide new leads for product enhancement by genetic modification of the organism. Also, development of molecular tools for strain improvement are emerging rapidly, making E. gracilis a noteworthy challenger for microalgae such as Chlorella spp. and their products currently on the market.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/155559